Mollaret meningitis may be caused by reactivation of latent cerebral toxoplasmosis

International Journal of Neuroscience

Volumn 119, Issue 10, 2009, Pages 1655-1692

  Prandota, Joseph ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Aseptic meningitis; Benign recurrent cerebral toxoplasmosis; Herpes simplex virus type 2; Mollaret's meningitis; Recurrent headaches; Transient neurologic abnormalities

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 6; INTERLEUKIN 8; METARAMINOL; REACTIVE OXYGEN METABOLITE; TRYPTOPHAN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASEPTIC MENINGITIS; CATECHOLAMINE BLOOD LEVEL; CONTROLLED STUDY; EPIDERMOID CYST; FEMALE; HOST RESISTANCE; IMMUNE RESPONSE; MALE; MOUSE; MULTIGENE FAMILY; NONHUMAN; RECURRENT DISEASE; TH2 CELL; TOXOPLASMA GONDII; TOXOPLASMOSIS;

CYTOKINES; FEMALE; HERPESVIRUS 2, HUMAN; HUMANS; MEDLINE; MENINGITIS; RETROSPECTIVE STUDIES; TOXOPLASMA; TOXOPLASMOSIS, CEREBRAL;

EID: 70350447964     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.1080/00207450802480044     Document Type: Article

References (229)

1. Achard, J. M., Lallement, P. Y., & Veyssier, P. (1990). Recurrent aseptic meningitis secondary to intracranial epidermoid cyst and Mollaret's meningitis: Two distinct entities or a single disease? A case report and a nosologic discussion. American Journal of Medicine, 89, 807-810.
2. Agarwal, S. K., & Marshall, G. D., Jr. (2000). Beta-adrenergic modulation of human type-1/type-2 cytokine balance. Journal of Allergy and Clinical Immunology, 105, 91-98.
3. Ahn, J. K., Yu, H. G., Chung, H.,&Park, Y. G. (2006). Intraocular cytokine environment in active Behcet uveitis. American Journal of Ophthalmology, 142, 429-434.
4. Appenzeller, S., Kobayashi, E., Costallat, L. T., Zanardi, V. D., Ribeiro Neto, J. M., Damasceno, B. P., et al (2000). Magnetic resonance imaging in the evaluation of patients with aseptic meningoencephalitis and connective tissue disorders. Arquivos de Neuro-Psiquiatria, 58, 45-51.
5. Arena, A., Liberto, M. C., Iannello, D., Capozza, A. B., & Foca, A. (1999). Altered cytokine production after human herpes virus type 6 infection. New Microbiology, 22, 293-300.
6. Aridogan, B. C., Yildirim, M., Baysal, V., Inaloz, H. S., Baz, K., & Kaya, S. (2003). Serum IL-4, IL-10, IL-12, IL-13 and IFN-gamma in Behcet's disease. Journal of Dermatology, 30, 602-607.
7. Aristegui, F. J., Delgado, R. A., Oleaga, Z. L., & Hermosa, C. C. (1998). Mollaret's recurrent aseptic meningitis and cerebral epidermoid cyst. Pediatric Neurology, 18, 156-159.
8. Arita, J., Tomikawa, M., Matsushima, H., Eto, Y., & Morikawa, T. (2003) Rhythmic fast activity on EEG in a patient with Mollaret's meningitis. No To Hattatsu, 35, 239-242.
9. Bamborschke, S., Sandmann, J., &Wullen, T. (1990).Mollaret benign recurrent aseptic meningitis. Case report, results of cerebrospinal fluid cytology and review of the literature. Nervenarzt, 61, 615-619.
10. Bansal, M. P., & Shalini, S. (2005). Effect of cholesterol and 7-beta hydroxycholesterol on glutathione status and nitric oxide production in murine peritoneal macrophages. Indian Journal of Experimental Biology, 43, 503-508.
11. Barakat, M. H., El-Khawad,A.O., Gumaa, K. A., El-Sobki,N. I.,&Fenech, F. F. (1984). Metaraminol provocative test: A specific diagnostic test for familialMediterranean fever. Lancet, 1, 656-657.
12. Barakat, M. H., Gumaa, K. A., Malhas, L. N., El-Sobki, N. I., Moussa, M. A., & Fenech, F. F. (1988). Plasma dopamine beta-hydroxylase: Rapid diagnostic test for recurrent hereditary polyserositis. Lancet, 8623, 1280-1283.
13. Barakat, M. H., Malhas, L. N., & Gumaa, K. K. (1989). Catecholamine metabolism in recurrent hereditary polyserositis. Pathogenesis of acute inflammation: The retention-likeage hypothesis. Biomedical Pharmacotherapy, 43, 763-769.
14. Barakat, M. H.,Mustafa,H. T.,&Shakir, R. A. (1988a). Mollaret'smeningitis.Avariant of recurrent hereditary polyserositis, both provoked by metaraminol. Archives of Neurology, 45, 926-927.
15. Baringer, J. R. (1974). Recovery of herpes simplex virus from human sacral ganglions. New England Journal of Medicine, 291, 828-830.
16. Barontini, F.,Ghezzi,M.,&Marconi,G. P. (1981).Acase of benign recurrent meningitis of Mollaret. Journal of Neurology, 225, 197-206.
17. Baskin, H., Yazici, Z., Baskin, Y., Olgun, N., Ozkul, A., & Bahar, I. H. (2005). Effects of non toxic doses of acyclovir on nitric oxide and cellular death responses in herpesvirus types 1 and 2 infected hep-2 cells. New Microbiologica, 28, 205-213.
18. Beaman,M. H., Hunter, C. A., & Remington, J. S. (1994). Enhancement of intracellular replication of Toxoplasma gondii by IL-6. Interactions with IFN-gamma and TNFalpha. Journal of Immunology, 153, 4583-4587.
19. Becker, W. J., Watters, G. V., de Chadarevian, J. P., & Vanasse, M. (1984). Recurrent aseptic meningitis secondary to intracranial epidermoids. Canadian Journal of Neurological Sciences, 11, 387-389.
20. Belmont, H. M., Levartovsky, D., Goel, A., Amin, A., Giorno, R., Rediske, J., et al. (1997). Increased nitric oxide production accompanied by the up-regulation of inducible nitric oxide synthase in vascular endothelium from patientswith systemic lupus erythematosus. Arthritis and Rheumatism, 40, 1810-1816.
21. Benedetto, N., Folgore, A., Galdiero, F., Meli, R., & Di Carlo, R. (1995). Effect of prolactin, rIFN-gamma or rTNF-alpha in murine toxoplasmosis. Pathology and Biology (Paris), 43, 395-400.
22. Benedetto, N., Folgore, A., Romano Carratelli, C., & Galdiero, F. (2001). Effects of cytokines and prolactin on the replication of Toxoplasma gondii in murine microglia. European Cytokine Network, 12, 348-358.
23. Bergmann, M., & Sautner, T. (2002). Immunomodulatory effects of vasoactive catecholamines. Wiener Klinische Wochenschrift, 114, 752-761.
24. Berger, J. R. (1991). Benign aseptic (Mollaret's) meningitis after genital herpes. Lancet, 337, 1360-1361.
25. Bourgouin, P. M., Melancon, D., Carpenter, S., Tampieri, D., & Ethier, R. (1992). Hydrocephalus and prominence of the choroid plexus: An unusual computed tomographic presentation of cerebral toxoplasmosis in AIDS. Canadian Association Radiology Journal, 43, 55-59.
26. Brabin, L.,&Brabin, B. J. (1992). Parasitic infections inwomen and their consequences. Advances in Parasitology, 31, 1-60.
27. Bruyn, G. W., Straathof, L. J., & Raymakers, G. M. (1962). Mollaret's meningitis. Differential diagnosis and diagnostic pitfalls. Neurology, 12, 745-753.
28. Burdin, N., Peronne, C., Banchereau, J., & Rousset, F. (1993). Epstein-Barr virus transformation induces B lymphocytes to produce human interleukin 10. Journal of Experimental Medicine, 177, 295-304.
29. Canoso, J. J., & Cohen, A. S. (1975). Aseptic meningitis in systemic lupus erythematosus. Report of three cases. Arthritis and Rheumatism, 18, 369-374.
30. Capouya, J. D., Berman, D. M., & Dumois, J. A. (2006). Mollaret's meningitis due to human herpesvirus 6 in an adolescent. Clinical Pediatrics (Phila), 45, 861-863.
31. Chahade,W. H., Soares, V. F., Guimaraes, T., Berbert, S. O., Szwarc, I. S., & Levi, G. C. (1994). Behcet's syndrome/AIDS/cerebral toxoplasmosis: An unusual association. Sao Paulo Medical Journal, 112, 587-590.
32. Chan, G. H., & Fiscus, R. R. (2004). Exaggerated production of nitric oxide (NO) and increases in inducible NO-synthase mRNA levels induced by the proinflammatory cytokine interleukin-1beta in vascular smooth muscle cells of elderly rats. Experimental Gerontology, 39, 387-394.
33. Chan, T. Y., Parvani, A. V., Levi, A.W., & Ali, S. Z. (2003). Mollaret's meningitis: Cytopathologic analysis of fourteen cases. Diagnostic Cytopathology, 28, 227-231.
34. Chang, D. M., Su, W. L., & Chu, S. J. (2002). The expression and significance of intracellular T helper cytokines in systemic lupus erythematosus. Immunology Investigation, 31, 1-12.
35. Chapelon-Abric, C. (2006). Neurosarcoidosis. Revue Neurologique (Paris), 162, 1173-1188.
36. Chez, M., Sila, C. A., Ransohoff, R. M., Longworth, D. L., & Weida, C. (1989). Ibuprofen-induced meningitis: Detection of intrathecal IgG synthesis and immune complexes. Neurology, 39, 1578-1580.
37. Cohen, J. H., Danel, L., Cordier, G., Saez, S., & Revillard, J. P. (1983). Sex steroid receptors in peripheral T cells: Absence of androgen receptors and restriction of estrogen receptors to OKT8-positive cells. Journal of Immunology, 131, 2767-2771.
38. Collard, M., Sellal, F., Hirsch, E., Mutschler, V., & Marescaux, C. (1991). Recurrent aseptic meningitis in periodic disease or Mollaret's meningitis?. Revue Neurologique (Paris), 147, 403-405.
39. Collins, J. L. l., Vodovotz, Y., Yoneyama, T., Hatakeyama, K., Green, A.M.,&Billiar, T. R. (2001).Catecholamines decrease nitric oxide production by cytokine-stimulated hepatocytes. Surgery, 130, 256-264.
40. Crossley, G. H., & Dismukes, W. E. (1990). Central nervous system epidermoid cyst: a probable etiology of Mollaret's meningitis. American Journal of Medicine, 89, 805-806.
41. Czonkowska, A., Ciesielska, A., Gromadzka, G., & Kurkowska- Jastrzebska, I. (2005). Estrogen and cytokines production-the posssible cause of gender differences in neurological diseases. Current Pharmaceutical Design, 11, 1017-1030.
42. Damico, F. M., Cunha-Neto, E., Goldberg, A. C., Iwai, L. K., Marin, M. L., Hammer, J., et al. (2005). T-cell recognition and cytokine profile induced by melanocyte epitopes in patientswithHLA-DRB10405-positive and -negativeVogt-Koyanagi-Harada uveitis. Investigative Ophthalmology & Visual Science, 46, 2465-2471.
43. Davis, L. E., Hodgin, U. G., & Kornfeld, M. (1986). Recurrent meningoencephalitis with recovery from Behcet's disease. Western Journal of Medicine, 145, 238-239.
44. De Chadarevian, J. P., & Becker, W. J. (1980). Mollaret's recurrent aseptic meningitis: Relationship to epidermoid cysts. Light microscopic and ultrastructural cytologic studies of the cerebrospinal fluid. Journal of Neuropathology and Experimental Neurology, 39, 661-669.
45. De La Torre-Silva, C., Aranda-Garcia, M., Perez-Assef, A., Hernandez-Biquiristain, J. D., & Gomez-Plasencia, R. (2002). Recurrent meningitis in Behcet's disease. A case report. Revista de Neurologia, 34, 298-299.
46. Dello Russo, C., Boullerne, A. I., Gavrilyuk, V., & Feinstein, D. L. (2004). Inhibition of microglial inflammatory responses by norepinephrine: Effects on nitric oxide and interleukin-1beta production. Journal of Neuroinflammation, 1, 9.
47. Desguerre, I., & Ponsot, G. (1993). Acquired cerebral toxoplasmosis in a nonimmunosuppressed child. Archives Francaise de Pediatrie, 50, 339-342.
48. Diehl, S., & Rincon, M. (2002). The two faces of IL-6 on Th1/Th2 differentiation. Molecular Immunology, 39, 531-536.
49. Dimayuga, F. O., Reed, J. L., Carnero, G. A.,Wang, C., Dimayuga, E. R., Dimayuga, V. M., et al. (2005). Estrogen and brain inflammation: Effects onmicroglial expression of MHC, costimulatory molecules and cytokines. Journal of Neuroimmmunology, 161, 123-136.
50. Dodge, J. C., & Badura, L. L. (2004). Noradrenergic regulation of prolactin secretion at the level of the paraventricular nucleus of the hypothalamus: Functional significance of the alpha-1b and beta-adrenergic receptor subtypes. Brain Research, 1016, 240-246.
51. Dufourny, L., Leroy, D., & Warembourg, M. (2000). Differential effects of colchicine on the induction of nitric oxide synthase in neurons containing progesterone receptors of the guinea pig hypothalamus. Brain Research Bulletin, 52, 435-443.
52. Dylewski, J. S., & Bekhor, S. (2004). Mollaret's meningitis caused by herpes simplex virus type 2: Case report and literature review. European Journal of Clinical Microbiology and Infectious Diseases, 23, 560-562.
53. Elenkov, I. J., Wilder, R. L., Chrousos, G. P., & Vizi, E. S. (2000). The sympathetic nerve-An integrative interface between two supersystems: The brain and the immune system. Pharmacological Reviews, 52, 595-638.
54. Ellermann-Eriksen, S. (2005). Macrophages and cytokines in the early defence against herpes simplex virus. Virology Journal, 2, 59.
55. Erken, E., Ozer,H. T.,&Gunesacar,R. (2006). Plasma interleukin-10 and interleukin-12 levels in patients with familial Mediterranean fever. Rheumatology International, 26, 862-864.
56. Ertel, W., Morrison, M. H., Meldrum, D. R., Ayala, A., & Chaudry, I. H. (1992). Ibuprofen restores cellular immunity and decreases susceptibility to sepsis following hemorrhage. Journal of Surgery Research, 53, 55-61.
57. Evans, H. (1993). Cytology of Mollaret meningitis. Diagnostic Cytopathology, 9, 373-376.
58. Evans, B. D., & Vogel, W. H. (1977). Penetration of some 0-and/or N-methylated norepinephrine derivatives through the rat blood brain barrier. Research Communications in Chemistry Pathology and Pharmacology, 17, 61-76.
59. Falangola, M. F., & Petito, C. K. (1993). Choroid plexus infection in cerebral toxoplasmosis in AIDS patients. Neurology, 43, 2035-2040.
60. Farber, K., Pannasch, U., & Kettenmann, H. (2005). Dopamine and noradrenaline control distinct functions in rodent microglial cells. Molecular and Cell Neuroscience, 29, 128-138.
61. Fatoohi, A. F., Cozon, G. J. N., Greenland, T., Ferrandiz, J., Bienvenue, J., Picot, S., et al. (2002). Cellular immune responses to recombinant antigens in pregnant women chronically infected with Toxoplasma gondii. Clinical and Diagnostic Laboratory Immunology, 9, 704-707.
62. Feron, O., Dessy, C., Moniotte, S., Desagre, J.-P., & Balligand, J.-L. (1999). Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase. Journal of Clinical Investigation, 103, 897-905.
63. Ferro, A., Queen, L. R., Priest, R. M., Xu, B., Ritter, J. M., Poston, L. P., et al. (1999). Activation of nitric oxide syntahse by ?-adrenoceptors in human umbilical vein endothelium in vitro. British Journal of Pharmacology, 126, 1872-1880.
64. Flamand, L., Gosselin, J., D'Addario, M., Hiscott, J., Ablashi, D. V., Gallo, R. C., et al. (1991). Human herpesvirus 6 induces interleukin-1? and tumor necrosis factor alpha, but not interleukin-6, in peripheral blood mononuclear cell cultures. Journal of Virology, 65, 5105-5110.
65. Fonseca-Aten, M., Messina, A. F., Jafri, H. S., & Sanchez, P. J. (2005). Herpes simplex virus encephalitis during suppressive therapy with acyclovir in a premature infant. Pediatrics, 115, 804-809.
66. Frassanito,M.A., Dammacco,R., Cafforio, P.,&Dammacco, F. (1999).Th1 polarization of the immune response in Behcet's disease: A putative pathogenetic role of interleukin-12. Arthritis and Rheumatism, 42, 1967-1974.
67. Fredholm, B. B.,&Hedqvist, P. (1975). Indomethacin-induced increase in noradrenaline turnover in some rat organs. British Journal of Pharmacology, 54, 295-300.
68. Fujigaki, S., Saito, K., Takemura, M., Maekawa, N., Yamada, Y., Wada, H., et al. (2002). L-tryptophan-L-kynurenine pathway metabolism accelerated by Toxoplasma gondii infection is abolished in gamma-interferon-gene-deficient mice: Cross-regulation between inducible nitric oxide synthase and indoleamine-2,3-dioxygenase. Infection and Immunity, 70, 779-786.
69. Fuller, R. W., Snoddy, H. D., & Perry, K. W. (1981). Tissue levels of metaraminol and its metabolite, alpha-methylnorepinephrine, in control and 6-hydroxydopaminepretreated guinea pigs. Life Sciences, 29, 1271-1275.
70. Fuller, R. W., Snoddy, H. D., Perry, K. W., Bernstein, J. R., & Murphy, P. J. (1981a). Formation of alpha-methylnorepinephrine as a metabolite ofmetaraminol in guinea pigs. Biochemical Pharmacology, 30, 2831-2836.
71. Fuller, R.W., & Hemrick-Luecke, S. K. (1982). Methylation of norepinephrine and alpha-methylnorepinephrine in brain. Biochemical Pharmacology, 31, 3128-3130.
72. Gabrilovac, J., Zadjelovic, J., Osmak, M., Suchanek, E., Zupanovic, Z., & Boranic, M. (1988). NK cell activity and estrogen levels during normal human pregnancy. Gynecologic and Obstetric Investigation, 25, 165-172.
73. Gaddi, P. J., & Yap, G. S. (2007). Cytokine regulation of immunopathology in toxoplasmosis. Immunology and Cell Biology, 85, 155-159.
74. Galdi, A. P. (1979). Benign recurrent aseptic meningitis (Mollaret's meningitis): Case report and clinical review. Archives of Neurology, 36, 657-658.
75. Gao, B., Yang, J., Zhuang, S., Deng, Y., Yang, W., Yu, Y., et al. (2007). Mollaret meningitis associated with an intraspinal epidermoid cyst. Pediatrics, 120, e220-e224.
76. Gavrilyuk,V., Dello Russo, C., Heneka, M. T., Pelligrino, D.,Weinberg,G.,&Feinstein, D. L. (2002). Norepinephrine increases I kappa B alpha expression in astrocytes. Journal of Biological Chemistry, 277, 29662-29668.
77. Gazzinelli, R. T., Hakim, F. T., Hieny, S., Shearer, G.M., & Sher, A. (1991). Synergistic role of CD4+ andCD8+ lymphocytes in IFN-? production and protective immunity induced by an attenuated Toxoplasma gondii vaccine. Journal of Immunology, 146, 286-292.
78. Gets, J., & Monroy, F. P. (2005). Effects of alpha- and beta-adrenergic agonists on Toxoplasma gondii infection in murine macrophages. Journal of Parasitology, 91, 193-195.
79. Ginsberg, L. (2004). Difficult and recurrent meningitis. Journal of Neurology Neurosurgery and Psychiatry, 75, i16-21.
80. Gober, M. D.,Wales, S. Q., & Aurelian, L. (2005). Herpes simplex virus type 2 encodes a heat shock protein homologue with apoptosis regulatory functions. Frontiers in Bioscience, 10, 2788-2803.
81. Goldstein, R.,Guberman,A., Izaguirre, C.A.,&Karsh, J. (1986).Mollaret'smeningitis: A case with increasing circulating natural killer cells. Annals of Neurology, 20, 359-361.
82. Gomez, D., Correa, P. A., Gomez, L. M., Cadena, J., Molina, J. F., & Anaya, J. M. (2004). Th1/Th2 cytokines in patients with systemic lupus erythematosus: Is tumor necrosis factor alpha protective?. Seminars in Arthritis and Rheumatism, 33, 404-413.
83. Gomez-Guerrero, C., Lopez-Franco, O., Suzuki, Y., Sanjuan, G., Hernandez-Vargas, P., Blanco, J., et al. (2002). Nitric oxide production in renal cells by immune complexes: Role of kinases and nuclear factor-kappaB. Kidney International, 62, 2022-2034.
84. Gornikiewicz, A., Sautner, T., Brostjan, C., Schmierer, B., Fugger, R., Roth, E., et al. (2000). Catecholamines up-regulate lipopolysaccharide-induced IL-6 production in human microvascular endothelial cells. FASEB Journal, 14, 1093-1100.
85. Gosselin, J., Flamand, L., D'Addario, M., Hiscott, J., Stefanescu, I., Ablashi, D. V., et al. (1992). Modulatory effects of Epstein-Barr, herpes simplex, and human herpes-6 viral infections and coinfections on cytokine synthesis. A comparative study. Journal of Immunology, 149, 181-187.
86. Graman, P. S. (1987). Mollaret's meningitis associated with acute Epstein-Barr virus mononucleosis. Archives of Neurology, 44, 1204-1205.
87. Grange-Messent, V., Raison, D., Dugas, B., & Calas, A. (2004). Noradrenaline up-regulates the neuronal and the inducible nitric oxide synthase isoforms in magnocellular neurons of rat brain slices. Journal of Neuroscience Research, 78, 683-690.
88. Grasso, G., & Muscettola, M. (1990). The influence of beta-estradiol and progesterone on interferon gamma production in vitro. International Journal of Neuroscience, 51, 315-317.
89. Grippo, J., Zochci, G., Fleiderman, S., & Asis, A. (2002). Behçet's disease in children. Cortical calcifications. Revista de Neurologia, 35, 209-211.
90. Guk, S. M., Kook, J., Jeon, Y. H., Choi, J. H., Han, E. T., Shin, E. H., et al. (2005). Suppressed cytokine and immunoglobulin secretions by murine splenic lymphocytes infected in vitro with Toxoplasma gondii tachyzoites. Journal of Parasitology, 91, 467-470.
91. Guntupova, L. D., Borisov, S. E., Kupavtseva, E. A., Mikhailova, L. P., & Makarova, O. V. (2006). The cytokine profile in granulomatous lung disease. Problemy Tuberkuleza i Bolezeni Legkikh, 6, 10-14.
92. Hajjar, D. P., & Haberland, M. E. (1997). Lipoprotein trafficking in vascular cells. Molecular Trojan horses and cellular saboteurs. Journal of Biological Chemistry, 272, 22975-22978.
93. Halonen, S. K., Taylor, G. A., & Weiss, L. M. (2001). Gamma interferon-induced inhibition of Toxoplasma gondii in astrocytes is mediated by IGTP. Infection and Immunity, 69, 5573-5576.
94. Hamzaoui, K., Hamzaoui, A., Guemira, F., Bessioud, M., Hamza, M., & Ayed, K. (2002). Cytokine profile in Behcet's disease patients. Relationship with disease activity. Scandinavian Journal of Rheumatology, 31, 205-210.
95. Harbrecht, B. G., Kim, Y. M., Wirant, E. M., Shapiro, R. A., & Billiar, T. R. (1996). PGE2 and LTB4 inhibit cytokine-stimulated nitric oxide synthase type 2 expression in isolated rat hepatocytes. Prostaglandins, 52, 103-116.
96. Hedge, S., Pahne, J., & Smola-Hess, S. (2004). Novel immunosuppressive properties of interleukin-6 in dendritic cells: Inhibition of NF-kappaB binding activity and CCR7 expression. FASEB Journal, 18, 1439-1441.
97. Hendler, N., Schlaeffer, F., Zirkin, H., Rabinowitz, B., & Berginer, V. M. (1991). Mollaret's meningitis in association with delivery in a Bedouin woman: A case report. European Journal of Obstetrics Gynecology and Reproductive Biology, 39, 77-79.
98. Hermans, P. E., Goldstein, N. P., & Wellman, W. E. (1972). Mollaret's meningitis and differential diagnosis of recurrent meningitis. Report of case, with review of the literature. American Journal of Medicine, 52, 128-140.
99. Heufler, C., Koch, F., Stanzl, U., Topar, G., Wysocka, M., Trinchieri, G, et al. (1996). Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-gamma production by T helper cells. European Journal of Immunology, 26, 659-668.
100. Himmerich, H., Fulda, S., Linseisen, J., Seiler, H., Wolfram, G., Himmerich, S., et al. (2006). TNF-alpha, soluble TNF receptor and interleukin-6 plasma levels in the general population. European Cytokine Network, 17, 196-201.
101. Hoitsma, E., Faber, C. G., Drent, M., & Sharma, O. P. (2004). Neurosarcoidosis: A clinical dilemma. Lancet Neurology, 3, 397-407.
102. Hrabak, A., Vercruysse, V., Kahan, I. L., & Vray, B. (2001). Indomethacin prevents the inducible nitric oxide synthase in murine peritoneal macrophages and decreases their nitric oxide production. Life Sciences, 68, 1923-1930.
103. Huang, Y. P., Perrin, L. H.,Miescher, P. A., & Zubler, R. H. (1988). Correlation of T and B cell activities in vitro and serum IL-2 levels in systemic lupus erythematosus. Journal of Immunology, 141, 827-832.
104. Hunter, C. A., Roberts, C. W., & Alexander, J. (1992). Kinetics of cytokine mRNA in the brains of mice with progressive toxoplasmic encephalitis. European Journal of Immunology, 22, 2317-2322.
105. Huppertz, H. I.,&Michels,H. (1988). The metaraminol provocation test in the diagnosis of familial Mediterranean fever. Monatsschrift Kinderheilkunde, 136, 243-245.
106. Ikari, H., Kuzuya, M., Yoshimine, N., Sugita, Y., & Kazuya, F. (1993). A case of indomethacin-inhibited recurrent periodical attacks of Mollaret's meningitis. Nippon Ronen Igakkai Zasshi, 30, 216-221.
107. Imai, Y., Sugita, M., Nakamura, S., et al. (2001). Cztokine production and helper T cell subsets in Vogt-Koyanagi-Harada's disease. Current Eye Research, 22, 312-318.
108. Inomata, H., & Kato, M. (1989). Vogt-Koyanagi-Harada disease. In R. R. McKendall (ed.), Handbook of Clinical Neurology, Vol.12 North-Holl and Amsterdam, 611-626.
109. Johnson, J. D., Campisi, J., Sharkey, C. M., Kennedy, S. L., Nickerson, M., Greenwood, B. N., et al. (2005). Catecholamines mediate stress-induced increases in peripheral and central inflammatory cytokines. Neuroscience, 135, 1295-1307.
110. Kalinski, P., Vieira, P. L., Schuitemaker, J. H., de Jong, E. C., & Kapsenberg, M. L. (2001). Prostaglandin E(2) is a selective inducer of interleukin-12p40 (IL-12p40) production and an inhibitor of bioactive IL-12p70 heterodimer. Blood, 97, 3466-3469.
111. Kamondi, A., Szegedi, A., Papp, A., Seres, A., & Szirmai, I. (2000). Vogt-Koyanagi-Harada disease presenting initially as aseptic meningoencephalitis. European Journal of Neurology, 7, 719-722.
112. Kaneko, Y. S., Mori, K., Nakashima, A., Sawada, M., Nagatsu, I., & Ota, A. (2005). Peripheral injection of lipopolysaccharide enhances expression of inflammatory cytokines in murine locus coeruleus: Possible role of increased norepinephrine turnover. Journal of Neurochemistry, 94, 393-404.
113. Katayama, H., Kohara, K., Igase, M.,Maguchi,M., Fukuoka, T., Okura, T., et al. (1997). Mollaretmeningitis associated with a high level of cytokines in cerebrospinal fluid. Nippon Ronen Igakkai Zasshi, 34, 65-69.
114. Kato, Y., Kurimura, M., Yahata, Y., Tajima, K., & Kato, T. (2006). Vogt-Koyanagi-Harada's disease presenting polymorphonuclear pleocytosis in the cerebrospinal fluid at the early active stage. Internal Medicine (Tokyo, Japan), 45, 779-781.
115. Kaul, D. (2001). Molecular links between cholesterol, cytokines and atherosclerosis. Molecular Cell Biochemistry, 219, 65-71.
116. Kavelaars, A., van de Pol, M., Zijlstra, J., & Heijnen, C. J. (1997). Beta 2-adrenergic activation enhances interleukin-8 production by human monocytes. Journal of Neuroimmunology, 77, 211-216.
117. Khan, E. A., & Correa, A. G. (1997). Toxoplasmosis of the central nervous system in non-human immunodeficiency virus-infected children: Case report and review of the literature. Pediatric Infectious Diseases Journal, 16, 611-618.
118. Kinnman, J., Kam-Hansen, S., Link, H.,&Norrby, E. (1979). Studies on the humoral and cell-mediated immune response in a patient with Mollaret's meningitis. Journal of Neurological Science, 43, 265-275.
119. Kittas, S., Kittas, C., PaiziBiza, P., & Henry, L. (1984). A histological and immunohistochemical study of the changes induced in the brains of white mice by infection with Toxoplasma gondii. British Journal of Experimental Pathology, 65, 67-74.
120. Knudsen, J. H., Kjaersgaard, E., & Christensen, N. J. (1995) Individual lymphocyte subset composition determines cAMP response to isoproterenol in mononuclear cell preparations from peripheral blood. Scandinavian Journal of Clinical and Laboratory Investigation, 55, 9-14.
121. Kohm, A. P., & Sanders, V. M. (2001). Norepinephrine and ?2-adrenergic receptor stimulation regulate CD4+ T and B lymphocyte function in vitro and in vivo. Pharmacological Reviews, 53, 487-525.
122. Koklu, S., Ozturk, M. A.,Balci,M.,Yuksel,O., Ertenli, I.,&Kiraz, S. (2005). Interferongamma levels in familial Mediterranean fever. Joint Bone Spine, 72, 38-40. (Pubitemid 40169962)
123. Kuwasaki, N., Shoji, H., & Kaji, M. (1983). Clinical studies of meningitis in Vogt-Koyanagi-Harada disease. Shinkei Naika, 19, 155-158.
124. Lancman, M. E., Mesropian, H., & Granillo, R. J. (1989) Chronic aseptic meningitis in a patient with systemic lupus erythematosus. Canadian Journal of Neurological Sciences, 16, 354-356.
125. Li, Y., Schwabe, R. F., DeVries-Seimon, T., Yao, P. M., Gerbod-Giannone, M. C., Tall, A. R., et al. (2005). Free cholesterol-loaded macrophages are an abundant source of tumor necrosis factor-alpha and interleukin-6: Model of NF-kappaB- and map kinase-dependent inflammation in advanced atherosclerosis. Journal of Biological Chemistry, 280, 21763-21772.
126. Limburg, M., Feenstra, L., Lecluse, F. L., & Muller, H. P. (1985). Mollaret's meningitis responding to phenylbutazonum. A case report. Clinical Neurology and Neurosurgery, 87, 127-130.
127. Loza, M. J., Foster, S., Peters, S. P., & Penn, R. B. (2006). Beta-agonists modulate T-cell functions via direct actions on type 1 and type 2 cells. Blood, 107, 2052-2060.
128. Lu, L. Y., Cheng, H. H., Sung, P. K., Tai, M. H., Yeh, J. J., & Chen, A. (2005). Tumor necrosis factor-beta +252A polymorphism is associated with systemic lupus erythematosus in Taiwan. Journal of the Formosan Medical Association, 104, 563-570.
129. Luczynski, W., Stasiak-Barmuta, A., Krawczuk-Rybak, M., & Malinowska, I. (2005). Assessment of selected co-stimulatory, adhesion and activatory molecules and cytokines of Th(1)/Th(2) balance in acute lymphoblastic leukemia in children. Archivum Immunologiae et Therapiae Experimentalis, 53, 357-363.
130. Luder, C. G.,Algner, M., Lang, C.,Bleicher, N.,&Gross, U. (2003).Reduced expression of the inducible nitric oxide synthase after infection with Toxoplasma gondii facilitates parasite replication in activated murine macrophages. International Journal of Parasitology, 33, 833-844.
131. Lynn,W., & Lightman, S. (2004). Fever, headache, and visual blurring in a 17-year-old woman. PloS Medicine, October 1, e7.
132. Malmgaard, L., Paludan, S. R., Mogensen, S. C., & Ellermann-Eriksen, S. (2000). Herpes simplex virus type 2 induces secretion of IL-12 by macrophages through a mechanism involving NF-?B. Journal of General Virology, 81, 3011-3020.
133. Masana, M. I., Heyes, M. P., & Mefford, I. N. (1990). Indomethacin prevents increased catecholamine turnover in rat brain following systemic endotoxin challenge. Progress in Neuro-psychopharmacology and Biological Psychiatry, 14, 609-621.
134. McLeod, R., & Remington, J. S. (1992). Toxoplasmosis. In R. E. Behrman, R. M. Kliegman, W. E. Nelson, & V. C. Vaughan (eds.), Nelson Textbook of Pediatrics 14th ed. Philadelphia: W.B. Saunders Co, 883-892.
135. Mege, J. L., Dilsen, N., Sanguedolce, V., Gul, A., Bongrand, P., Roux, H., et al. (1993). Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behçet's disease. A comparative study with familialMediterranean fever and healthy subjects. Journal of Rheumatology, 20, 1544-1549.
136. Mikdashi, J., Kennedy, S., & Krumholz, A. (2008). Recurrent benign lymphocytic (Mollaret) meningitis in systemic lupus erythematosus. Neurologist, 14, 43-45.
137. Minshall, E. M., Tsicopoulos, A., Yasruel, Z., Wallaert, B., Akoum, H., Vorng, H., et al. (1997). Cytokine mRNA gene expression in active and nonactive pulmonary sarcoidosis. European Respiratory Journal, 10, 2034-2049.
138. Mirakhur, B., &McKenna,M. (2004). Recurrent herpes simplex type 2 virus (Mollaret) meningitis. Journal of American Board Family Practice, 17, 303-305.
139. Miyazawa, I., Abe, T., Narikawa, K., Feng, J., Misu, T., Nakashima, I., et al. (2005). Chemokine profile in the cerebrospinal fluid and serum of Vogt-Koyanagi-Harada disease. Journal of Neuroimmunology, 158, 240-244.
140. Mollaret, P. (1944). La ḿeningite endoth́elio-leucocytaire multirecurrente b́enigne: Syndrome nouveau ou maladie nouvelle? (Documents cliniques). Revue de Neurologie (Paris), 76, 57-76.
141. Moller, D. R. (1999). Cells and cytokines involved in the pathogenesis of sarcoidosis. Sarcoidosis, Vasculitis and Diffuse Lung Diseases, 16, 24-31.
142. Monteyne, P., Sindic, C. J., & Laterre, E. C. (1996). Recurrent meningitis and encephalitis associated with herpes simplex type 2: Demonstration by polymerase chain reaction. European Neurology, 36, 176-177.
143. Montoya, J. G., & Liesenfeld, O. (2004). Toxoplasmosis. Lancet, 12, 1965-1976.
144. Mora, J. S., & Gimeno, A. (1980).Mollaret's meningitis: Report of a case with recovery after colchicine. Annals of Neurology, 8, 631-633.
145. Mori, K., Ozaki, E., Zhang, B., Yang, L., Yokoyama, A., Takeda, I., et al. (2002). Effects of norepinephrine on rat culturedmicroglial cells that express alpha1, alpha2, beta1 and beta2 adrenergic receptors. Neuropharmacology, 43, 1026-1034.
146. Mun, H.-S., Aosai, F., & Yano, A. (1999). Role of Toxoplasma gondii HSP70 and Toxoplasma gondii HSP30/bag1 in antibody formation and prophylactic immunity in mice experimentally infected with Toxoplasma gondii. Microbiology and Immunology, 43, 471-479.
147. Mun, H.-S., Norose, K., Aosai, F., Chen, M., & Yano, A. (2000). A role of carboxyterminal region of Toxoplasma gondii-heat shock protein 70 in enhancement of T. gondii infection in mice. The Korean Journal of Parasitology, 38, 107-110.
148. Oates, J. C., & Gilkeson, G. S. (2006). The biology of nitric oxide and other reactive intermediates in systemic lupus erythematosus. Clinical Immunology, 121, 243-250.
149. Oberdorfer, C., Adams, O., MacKenzie, C. R., De Groot, C. J., & Daubener,W. (2003). Role of IDO activation in anti-microbial defense in human native astrocytes. Advances in Experimental Medicine and Biology, 527, 15-26.
150. O'Duffy, J. D., & Goldstein, N. P. (1976). Neurologic involvement in seven patients with Behcet's disease. American Journal of Medicine, 61, 170-178.
151. Pampliega-Perez, A., Martin-Estefania, C., Caballe-Tura, M., Portilla-Sogorb, J., & Alvarez-Sauco, M. (2003). Aseptic meningitis caused by the rupture of an epidermoid cyst. Revista de Neurologia, 37, 221-224.
152. Periard, D., Mayor, C., Aubert, V., & Spertini, F. (2006). Recurrent ibuprofeninduced aseptic meningitis: Evidence against an antigen-specific immune response. Neurology, 67, 539-540.
153. Pisani, E., Fattorello, C., Leotta, M. R., Marcello, O., & Zuliani, C. (1999). Recurrence of ibuprofen-induced aseptic meningitis in an otherwise healthy patient. Italian Journal of Neurological Sciences, 20, 59-62.
154. Plummer, G. (1973). Isolation of herpesviruses from trigeminal ganglia of man, monkeys, and cats. Journal of Infectious Diseases, 128, 345-347.
155. Prandota, J. (2007). Recurrent headache as the main symptom of acquired cerebral toxoplasmosis in non-human immunodeficiency virus-infected subjects with no lymphadenopathy. The parasite may be responsible for the neurogenic inflammation postulated as a cause of different types of headaches. American Journal of Therapeutics, 14, 63-105.
156. Prandota, J. (2009a). Idiopathic intracranial hypertension may be due to reactivation of latent cerebral toxoplasmosis. Effects of medications and biologic substances. Recent Patents on CNS Drug Discovery, (in press).
157. Prandota, J. (2009b). Idiopathic intracranial hypertension may be caused by reactivation of latent cerebral toxoplasmosis. Effect of various diseases and clinical states. International Journal of Neuroscience, (in press).
158. Prinz, M., Hausler, K. G., Kettenmann, H., & Hanisch, U. (2001). Beta-adrenergic receptor stimulation selectively inhibits IL-12p40 release in microglia. Brain Research, 899, 264-270.
159. Procop, G. W., Yen-Lieberman, B., Prayson, R. A., & Gordon, S. M. (2004). Mollaretlike cells in patients withWest Nile virus infection. Emerging Infectious Diseases, 10, 753-754.
160. Puder, J. J., Freda, P. U., Goland, R. S.,&Wardlaw, S. L. (2001). Estrogen modulates the hypothalamic-pituitary-adrenal and inflammatory cytokine responses to endotoxin in women. Journal of Clinical Endocrinology and Metabolism, 86, 2403-2408.
161. Rassler, B., Rohling, M. A., & Reissig, C. (2005). Involvement of cytokines and inflammation in catecholamine-induced pulmonary injury in rats. Vascular Diseases and Prevention, 2, 1-9.
162. Rizos, D., Protonotariou, E., Malamitsi-Puchner, A., Trakakis, E., Sarandakou, A., & Salamalekis, E. (2005). Inflammatory cytokines and their soluble receptors during delivery and early life. Acta Obstetrica and Gynecologica Scandinavica, 84, 817-818.
163. Roberts, C.W.,Cruickshank, S. M.,&Alexander, J. (1995). Sex-determined resistance to Toxoplasma gondii is associated with temporal differences in cytokine production. Infection and Immunity, 63, 2549-2555.
164. Rontgen, P., Sablotzki, A., Simm, A., Silber, R. E., & Czeslick, E. (2004). Effect of catecholamines in intracellular cytokine synthesis in human monocytes. European Cytokine Network, 15, 14-23.
165. Rothkrantz-Kos, S., van Dieijen-Visser, M. P., Mulder, P. G. H., & Drent, M. (2003). Potential usefulness of inflammatory markers to monitor respiratory functional impairment in sarcoidosis. Clinical Chemistry, 49, 1510-1517.
166. Rottach, K., Scheglmann, K., & Pfadenhauer, K. (1996). Mollaret's meningitis: A new etiologic feature. European Neurology, 36, 172-173.
167. Ruben, S. J. (1994).Mollaret's meningitis. Western Journal of Medicine, 160, 459-462.
168. Sakamaki, K., Nomura, M., Yamato, K., & Tanaka, J. (2004). GABA-mediated attenuation of noradrenaline release in the rat median preoptic area caused by intravenous injection of metaraminol. Autonomic Neuroscience, 111, 7-14.
169. Sakane, T., Takeno, M., Suzuki, N., & Inaba, G. (1999). Behçet's disease. New England Journal of Medicine, 341, 1284-1291.
170. Sanders, V. M., Baker, R. A., Ramer-Quinn, D. S., Kasprowicz, D. J., Fuchs, B. A., & Street, N. E. (1997). Differential expression of the beta2-adrenergic receptor by Th1 and Th2 clones: Implications for cytokine production and B cell help. Journal of Immunology, 158, 4200-4210.
171. Sato, R., Ayabe, M., Shoji, H., Ichiyama, T., Saito, Y., Hondo, R., et al. (2005). Herpes simplex virus type 2 recurrent meningitis (Mollaret's meningitis): A consideration for the recurrent pathogenesis. Journal of Infection, 51, e217-220.
172. Schmollack,W., & Steup, A. (1988). The effect of indomethacin and dexamethasone on the excretion of epinephrine, levarterenol and dopamine in the urine of rats with adjuvant arthritis. Pharmazie, 43, 110-113.
173. Seabra, S. H., de Souza, W., & DaMatta, R. A. (2002). Toxoplasma gondii partially inhibits nitric oxide production of activated murine macrophages. Experimental Parasitology, 100, 62-70.
174. Sell, M., Klingebiel, R., Di Iorio, G., & Sampaolo, S. (2005). Primary cerebral toxoplasmosis: A rare case of ventriculitis and hydrocephalus in AIDS. Clinical Neuropathology, 24, 106-111.
175. Sendi, P., & Graber, P. (2006). Mollaret's meningitis. Canadian Medical Association Journal, 174, 1710.
176. Setsuda, J., Teruya-Feldstein, J., Harris, N. L., Ferry, J. A., Sobara, L., Gupta, G., et al. (1999). Interleukin-18, interferon-?, and Mig expression in Epstein-Barr virus-induced infectious mononucleosis and posttransplant lymphoproliferative disease. American Journal of Pathology, 155, 257-265.
177. Shalabi, M.,&Whitley, R. J. (2006). Recurrent benign lymphocytic meningitis. Clinical Infectious Disease, 43, 1194-1197.
178. Sharma, O. P. (1997). Neurosarcoidosis. A personal perspective based on the study of 37 patients. Chest, 112, 220-228.
179. Sher, A., Gazzinelli, R. T., Oswald, I. P., Clerici, M., Kullberg, M., Pearce, E. J., et al. (1992). Role of T-cell derived cytokines in the downregulation of immune respones in parasitic and retroviral infection. Immunological Reviews, 127, 183-204.
180. Shigehara, K., Shijubo, N., Ohmichi, M., Yamada, G., Takahashi, R., Okamura, H., et al. (2000). Increased levels of interleukin-18 in patients with pulmonary sarcoidosis. American Journal of Respiratory and Critical Care Medicine, 162, 1979-1982. (Pubitemid 30947590)
181. Shigehara, K., Shijubo, N., Ohmichi, M., Kamiguchi, K., Takahashi, R., Morita-Ichimura, S., et al. (2003). Increased circulating interleukin-12 (IL-12) p40 in pulmonary sarcoidosis. Clinical and Experimental Immunology, 132, 152-157.
182. Shimeld, C., Easty, D. L., & Hill, T. J. (1999). Reactivation of herpes simplex virus type 1 in the mouse trigeminal ganglion: An in vivo study of virus antigen and cytokines. Journal of Virology, 73, 1767-1773.
183. Shukla, P. C., Ramachandran, T. S., & Iyer, U. (2006). Aseptic meningitis. eMedicine, Sept.
184. Silva, N. M., Gazzinelli, R. T., Silva, D. A. O., Perro, E. A. V., Kasper, L. H., & Mineo, J. R. (1998). Expression of Toxoplasma gondii-specific heat shock protein 70 during in vivo conversion of bradyzoites to tachyzoites. Infection and Immunity, 66, 3959-3963.
185. Smith,A., Santoro, F.,Di Lullo,G., Dangna, L.,Verani,A.,&Lusso, P. (2003). Selective suppression of IL-12 production by human herpesvirus 6. Blood, 102, 2877-2884.
186. Sorachi, K., Kumagai, S., Sugita, M., Yodoi, J., & Imura, H. (1993). Enhancing effect of 17 beta-estradiol on human NK cell activity. Immunology Letters, 36, 31-35.
187. Soucy, G., Boivin, G., Labrie, F., & Rivest, S. (2005). Estradiol is required for a proper immune response to bacterial and viral pathogens in the female brain. Journal of Immunology, 174, 6391-6398.
188. Spitzer, W. O., Suissa, S., Ernst, P., Horwitz, R. I., Habbick, B., Cockroft, D., et al. (1992). The use of ?-agonists and the risk of death and near-death from asthma. New England Journal of Medicine, 326, 501-506.
189. Stamm, A. M., Livingston, W. K., Cobbs, C. G., & Dismukes, W. E. (1984). Failure of colchicine in the treatment of Molaret's meningitis. Archives of Internal Medicine, 144, 2265-2266.
190. Steigerwald-Mullen, P., Kurilla, M. G., & Braciale, T. J. (2000). Type 2 cytokines predominate in the human CD4 +T-lymphocyte response to Epstein-Barr virus nuclear antigen 1. Journal of Virology, 74, 6748-6759.
191. Studnicka-Benke, A., Steiner, G., Petera, P., & Smolen, J. S. (1996). Tumour necrosis factor alpha and its soluble receptors parallel clinical disease and autoimmune activity in systemic lupus erythematosus. British Journal of Rheumatology, 35, 1067-1074.
192. Sun, K. H., Yu, C. L., Tang, S. J.,&Sun, G. H. (2000).Monoclonal anti-double-stranded DNA autoantibody stimulates the expression and release of IL-1beta, IL-6, Il-8, IL-10 and TNF-alpha from normal human mononuclear cells involving in the lupus pathogenesis. Immunology, 99, 352-360.
193. Suzuki,Y. (2002). Immunopathogenesis of cerebral toxoplasmosis. Journal of Infectious Diseases, 186 (suppl 2), S234-S240.
194. Suzuki, N., Nara, K., & Suzuki, T. (2006). Skewed Th1 responses caused by excessive expression of Txk, a member of the Tec family of throsine kinases, in patients with Behcet's disease. Clinical Medicine Research, 4, 147-151.
195. Suzuki, Y., Yang, Q., Yang, S., Nguyen, N., Lim, S., Lisenfeld, O., et al. (1996). IL-4 is protective against development of toxoplasmic encephalitis. Journal of Immunology, 157, 2564-2569.
196. Szabo, M., Majtenyi, C., & Guseo, A. (1983). Contribution to the background of Mollaret's meningitis. Acta Neuropathologica (Berl), 59, 115-118.
197. Takahashi, H. K., Iwagaki, H., Mori, S., Yoshino, T., Tanaka, N., & Nishibori, M. (2004). Beta 2-adrenergic receptor agonist induces IL-18 production without IL-12 production. Journal of Neuroimmunology, 151,137-147.
198. Takahashi, H. K., Morichika, T., Iwagaki, H., Yoshino, Y., Tamura, R., Saito, S., et al. (2003). Effect of ?2-adrenergic receptor stimulation in interleukin-18-induced intercellular adhesion molecule-1 expression and cytokine production. Journal of Pharmacology and Experimental Therapeutics, 304, 634-642.
199. Tamayo-Gomez, F., Menendez-Villa, M. L., Perez-Assef, A., Hernandez-Bequiristain, J. D., & Gomez-Plasencia, R. F. (2003) Sarcoidosis and idiopathic intracranial hypertension. A case report. Revista de Neurologia, 36, 237-238.
200. Tang, Y. W., Cleavinger, P. J., Li, H., Mitchell, P. S., Smith, T. F., & Persing, D. H. (2000). Analysis of candidate-host immunogenetic determinants in herpes simplex virus-associated Mollaret's meningitis. Clinical Infectious Diseases, 30, 176-178.
201. Taylor,M.W.,&Feng, G. (1991).Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism. Federation of American Societies for Experimental Biology Journal, 5, 2516-2522.
202. Tedder, D. G., Ashley, R., Tyler, K. L., & Levin, M. J. (1994). Herpes simplex virus infection as a cause of benign recurrent lymphocytic meningitis. Annals of Internal Medicine, 121, 334-338.
203. Ten Brinke, A., Dekkers, D. W. C., Notten, S. M., Karsten, M. L., De Groot, E. R., & Aarden, L. A. (2005) 4-hydroxy-oxyphenbutazone is a potent inhibitor of cytokine production. European Cytokine Network, 16, 144-151.
204. Tenter, A. M., Heckeroth, A. B., & Weiss, L. M. (2000). Toxoplasma gondii: From animals to humans. International Journal of Parasitology, 30, 1217-1258.
205. Thilmann, A. F., Mobius, E., Thilmann, R. R., & Topper, R. (1991). Recurrent aseptic meningitis (Mollaret's meningitis)-spontaneous and drug-induced origin. Fortschritte der Neurologie-Psychiatrie, 59, 493-497.
206. Triki, A., & Couvreur, J. (1971). Neuro-meningeal manifestations of acquired toxoplasmosis. Tunis Medicine, 49, 323-329.
207. Tsuboi, I., Tanaka, H., Nakao, M., Shichijo, S., & Itoh, K. (1995). Nonsteroidal anti-inflammatory drugs differentially regulate cytokine production in human lymphocytes: Up-regulation of TNF, IFN-gamma and IL-2, in contrast to downregulation of IL-6 production. Cytokine, 7, 372-379.
208. Tyler, K. L., & Adler, D. (1983). Twenty-eight years of benign recurring Mollaret meningitis. Archives of Neurology, 40, 42-43.
209. Tyler, K. L. (2004). Herpes simplex virus infections of the central nervous system: Encephalitis and meningitis, including Mollaret's. Herpes, 11(Suppl 2), 57A-64A.
210. Vanhatalo, S., Lumme, A., & Soinila, S. (1998). Colchicine differentially induces the expressions of nitric oxide synthases in central and peripheral catecholaminergic neurons. Experimental Neurology, 150, 107-114.
211. Vilaseca, J., Tor, J., Guardia, J., & Bacardi, R. (1982). Periodic meningitis and familial Mediterranean fever. Archives of Internal Medicine, 142, 378-379.
212. Vukmirovits, G., Juhasz, P., Janko, M., & Toth, L. (1985). Acute monosymptomatic aseptic meningitis caused by Toxoplasma gondii. Acta Paediatrica Hungarica, 26, 31-34.
213. Wahle, M., Neumann, R. P., Moritz, F., Krause, A., Buttgereit, F., & Baerwald, C. G. (2005). Beta 2-adrenergic receptors mediate the differential effects of catecholamines on cytokine production of PBMC. Journal of Interferon Cytokine Research, 25, 384-394.
214. Wang, X., & Suzuki, Y. (2007). Microglia produce IFN-gamma independently from T cells during acute toxoplasmosis in the brain. Journal of Interferon Cytokine Research, 27, 599-605.
215. Wang, F., Yao, K., Yin, Q. Z., Zhou, F., Ding, C. L., Peng, G. Y., et al. (2006). Human herpesvirus-6-specific interleukin 10-producing CD4+ T cells suppress the CD4+ T-cell response in infected individuals. Microbiology and Immunology, 50, 787-803.
216. Warren, K. G., Devlin,M., Gilden, D. H., Wroblewska, Z., Brown, S.M., Subak-Sharpe, J., et al. (1977). Isolation of herpes simplex virus from human trigeminal ganglia, including ganglia from one patient with multiple sclerosis. Lancet, 2, 637-639.
217. Wei, G., Zhang, M.,Mei, Y.,&Dong, J. (2006). Expression of cytokines IL-2, IL-10 and TNF-alpha in mice with herpes simplex viral encephalitis. Journal of Huazhong University of Science and Technology. Medical Sciences, 26, 308-310.
218. Weiss, M. A., Gebarski, S. S.,&McKeever, P. E. (1996). Foramen magnum neuroenteric cyst causing Mollaret meningitis: MR findings. AJNR American Journal of Neuroradiology, 17, 386-388.
219. Wiendels, N. J., Knuistingh Neven, A., Rosendaal, F. R., Spinhoven, P., Zitman, F. G., Assendelft,W. J., et al(2006). Chronic frequent headache in the general population: Prevalence and associated factors. Cephalalgia, 26, 1434-1442. (Pubitemid 44777857)
220. Wu, C. H., Chen, T. L., Chen, T. G., Ho,W. P., Chiu,W. T., & Chen, R. M. (2003). Nitric oxide modulates pro- and anti-inflammatory cytokines in lipopolysaccharideactivated macrophages. Journal of Trauma, 55, 540-545.
221. Wynants, H., Taelman, H., Martin, J. J., & Van Den Ende, J. (2000). Recurring aseptic meningitis after travel to the tropics: A case of Mollaret's meningitis? Case report with review of the literature. Clinical Neurology and Neurosurgery, 102, 113-115.
222. Yamauchi, Y., Wada, K., Goshima, F., Daikoku, T., Ohtsuka, K., & Nishiyama, Y. (2002). Herpes simplex virus type 2 UL14 gene product has heat shock protein (HSP)-like functions. Journal of Cell Science, 115, 2517-2527.
223. Yap, G., Pesin, M., & Sher, A. (2000). Cutting edge: IL-12 is requried for the maintenance of IFN-? production in T cells mediating chronic resistance to the intracellular pathogen, Toxoplasma gondii. Journal of Immunology, 165, 628-631.
224. Yeh, S.-S., & Schuster, M. W. (1999). Geriatric cachexia: The role of cytokines. American Journal of Clinical Nutrition, 70, 183-197.
225. Yokoyama,T., Kanda,T.,Kobayashi, I.,&Suzuki,T. (1995). Serum levels of interleukin-8 as a marker of disease activity in the patients with chronic sarcoidosis. Journal of Medicine, 26, 209-219.
226. Ytterberg, S. R., & Schnitzer, T. J. (1982). Serum interferon levels in patients with systemic lupus erythematosus. Arthritis and Rheumatism, 25, 401-406.
227. Zhang, X. L., Komada, Y., Chipeta, J., Li, Q. S., Inaba, H., Azuma, E., et al. (2000). Intracellular cytokine profile of T cells from children with acute lymphoblastic leukemia. Cancer Immunology and Immunotherapy, 49, 165-172.
228. Zinyama, R. B., Banckroft, G. J., & Sigola, L. B. (2001). Adrenaline suppression of the macrophage nitric oxide response to lipopolysaccharide is associated with differential regulation of tumor necrosis factor-alpha and interleukin-10. Immunology, 104, 439-446.
229. Zumwalt, J. W., Thunstrom, B. J., & Spangelo, B. L. (1999). Interleukin-1beta and catecholamines synergistically stimulate interleukin-6 release from rat C6 glioma cells in vitro: A potential role for lysophosphatidilcholine. Endocrinology, 140, 888-896.